AWM
GILD icon

Adams Wealth Management’s Gilead Sciences GILD Stock Holding History

Adams Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$855K Buy
6,766
+1,479
+28% +$195K 0.16% 79
2026
Q1 		$737K Buy
5,287
+315
+6% +$44.1K 0.16% 75
2025
Q4 		$610K Sell
4,972
-301
-6% -$36.6K 0.13% 82
2025
Q3 		$585K Sell
5,273
-620
-11% -$70.5K 0.13% 85
2025
Q2 		$653K Buy
+5,893
New +$627K 0.12% 80
2020
Q4 		– Sell
-850
Closed -$54K – 177
2020
Q3 		$54K Buy
+850
New +$58.9K 0.04% 105

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adams Wealth Management's GILD Position: Q2 2026 in Review

Adams Wealth Management increased its Gilead Sciences (GILD) stake by 28% in Q2 2026, buying an estimated $195K and bringing the position to 6,766 shares worth $855K. The position accounts for 0.16% of the portfolio, ranked #79.

Adams Wealth Management first reported a position in GILD in Q3 2020 and has held it in 6 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Adams Wealth Management held 6,766 shares of Gilead Sciences worth $855K as of Q2 2026.
  • Adams Wealth Management bought 1,479 Gilead Sciences shares in Q2 2026, an estimated $195K.
  • Gilead Sciences made up 0.16% of Adams Wealth Management's portfolio in Q2 2026, its #79 holding.
  • Adams Wealth Management first reported a position in Gilead Sciences in Q3 2020 and has held it in 6 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Adams Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.